Cargando…

PB2057: REAL -WORLD OVERALL SURVIVAL OF MYELOFIBROSIS PATIENTS ON RUXOLITINIB – A 6 YEAR ANALYSIS IN ALBANIAN POPULATION

Detalles Bibliográficos
Autores principales: Perolla, A., Pulluqi, P., Cili, A., Calliku, E., Caja, T., Ivanaj, A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9428968/
http://dx.doi.org/10.1097/01.HS9.0000851060.08910.17
_version_ 1784779285453602816
author Perolla, A.
Pulluqi, P.
Cili, A.
Calliku, E.
Caja, T.
Ivanaj, A.
author_facet Perolla, A.
Pulluqi, P.
Cili, A.
Calliku, E.
Caja, T.
Ivanaj, A.
author_sort Perolla, A.
collection PubMed
description
format Online
Article
Text
id pubmed-9428968
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-94289682022-08-31 PB2057: REAL -WORLD OVERALL SURVIVAL OF MYELOFIBROSIS PATIENTS ON RUXOLITINIB – A 6 YEAR ANALYSIS IN ALBANIAN POPULATION Perolla, A. Pulluqi, P. Cili, A. Calliku, E. Caja, T. Ivanaj, A. Hemasphere Publication Only Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9428968/ http://dx.doi.org/10.1097/01.HS9.0000851060.08910.17 Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Publication Only
Perolla, A.
Pulluqi, P.
Cili, A.
Calliku, E.
Caja, T.
Ivanaj, A.
PB2057: REAL -WORLD OVERALL SURVIVAL OF MYELOFIBROSIS PATIENTS ON RUXOLITINIB – A 6 YEAR ANALYSIS IN ALBANIAN POPULATION
title PB2057: REAL -WORLD OVERALL SURVIVAL OF MYELOFIBROSIS PATIENTS ON RUXOLITINIB – A 6 YEAR ANALYSIS IN ALBANIAN POPULATION
title_full PB2057: REAL -WORLD OVERALL SURVIVAL OF MYELOFIBROSIS PATIENTS ON RUXOLITINIB – A 6 YEAR ANALYSIS IN ALBANIAN POPULATION
title_fullStr PB2057: REAL -WORLD OVERALL SURVIVAL OF MYELOFIBROSIS PATIENTS ON RUXOLITINIB – A 6 YEAR ANALYSIS IN ALBANIAN POPULATION
title_full_unstemmed PB2057: REAL -WORLD OVERALL SURVIVAL OF MYELOFIBROSIS PATIENTS ON RUXOLITINIB – A 6 YEAR ANALYSIS IN ALBANIAN POPULATION
title_short PB2057: REAL -WORLD OVERALL SURVIVAL OF MYELOFIBROSIS PATIENTS ON RUXOLITINIB – A 6 YEAR ANALYSIS IN ALBANIAN POPULATION
title_sort pb2057: real -world overall survival of myelofibrosis patients on ruxolitinib – a 6 year analysis in albanian population
topic Publication Only
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9428968/
http://dx.doi.org/10.1097/01.HS9.0000851060.08910.17
work_keys_str_mv AT perollaa pb2057realworldoverallsurvivalofmyelofibrosispatientsonruxolitiniba6yearanalysisinalbanianpopulation
AT pulluqip pb2057realworldoverallsurvivalofmyelofibrosispatientsonruxolitiniba6yearanalysisinalbanianpopulation
AT cilia pb2057realworldoverallsurvivalofmyelofibrosispatientsonruxolitiniba6yearanalysisinalbanianpopulation
AT callikue pb2057realworldoverallsurvivalofmyelofibrosispatientsonruxolitiniba6yearanalysisinalbanianpopulation
AT cajat pb2057realworldoverallsurvivalofmyelofibrosispatientsonruxolitiniba6yearanalysisinalbanianpopulation
AT ivanaja pb2057realworldoverallsurvivalofmyelofibrosispatientsonruxolitiniba6yearanalysisinalbanianpopulation